HF
BDSX icon

HRT Financial’s Biodesix BDSX Stock Holding History

HRT Financial’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,388
Closed -$223K – 4201
2026
Q1 		$223K Buy
+15,388
New +$191K ﹤0.01% 3122
2025
Q2 		– Sell
-1,667
Closed -$20K – 2612
2025
Q1 		$20K Buy
+1,667
New +$32K ﹤0.01% 2300
2024
Q1 		– Sell
-1,184
Closed -$43K – 2335
2023
Q4 		$43K Sell
1,184
-1,942
-62% -$61K ﹤0.01% 1968
2023
Q3 		$103K Buy
+3,126
New +$86.8K ﹤0.01% 1946
2023
Q2 		– Sell
-1,645
Closed -$61K – 2472
2023
Q1 		$61K Buy
+1,645
New +$67.5K ﹤0.01% 2112
2022
Q3 		– Sell
-550
Closed -$18K – 2805
2022
Q2 		$18K Buy
+550
New +$17.9K ﹤0.01% 2619

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

HRT Financial's BDSX Position: Q2 2026 in Review

HRT Financial sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 15,388 shares — an estimated $223K sold.

HRT Financial first reported a position in BDSX in Q2 2022 and held it in 6 quarters. The position peaked at $223K in Q1 2026. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • HRT Financial reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 15,388 Biodesix shares in Q2 2026, an estimated $223K.
  • HRT Financial first reported a position in Biodesix in Q2 2022 and held it in 6 quarters.
  • HRT Financial's Biodesix position peaked at $223K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.